title: MicroRNA-9 inhibits vasculogenic mimicry of glioma cell lines by suppressing Stathmin expression.
abstract: The purpose of this study was to investigate the functions of microRNA-9, which is a tissue-specific microRNA in central nervous system, in the vasculogenic mimicry (VM) of glioma cell lines in vitro and in vivo. Glioma cell lines U87MG, U251 and SHG44 were transfected with microRNA-9 mimic, microRNA-9 inhibitor or scramble sequences. The amount of microRNA-9 and Stathmin (STMN1) mRNA was determined by quantitative real-time PCR, and the protein expression of STMN1 was determined by western blot. Cell proliferation and apoptosis were assessed. The interactions between the 3'UTR of STMN1 and miR-9 was determined by luciferase reporter assay. The VM capacity in vitro was evaluated using VM formation assay, and the rescue experiment of STMN1 was carried out in U251 cells. The in vivo experiment was applied with animal models implanted with U87MG cells.MicroRNA-9 mimic transfection reduced proliferation and increased apoptosis in glioma cell lines (p < 0.05). MicroRNA-9 mimic up-regulated STMN1 mRNA levels but reduced its protein levels (p < 0.05), and luciferase activity of STMN1 was suppressed by microRNA-9 mimic transfection (p < 0.05). Furthermore, microRNA-9 mimic transfection suppressed tumor volume growth, as well as VM both in vitro and in vivo. The cell viability and microtube density were upregulated in U251 cells after STMN1 up-regulation (p < 0.05). STMN1 is a target of microRNA-9, and microRNA-9 could modulate cell proliferation, VM and tumor volume growth through controlling STMN1 expression. MicroRNA-9 and its targets may represent a novel panel of molecules for the development of glioma treatment.
authors.affiliation: Department of Neurosurgery, The Fourth Affiliated Hospital of Harbin Medical University, No. 37, Yiyuan street, Harbin, 150001, People's Republic of China.
authors.forename: Yuwen
authors.initials: Y
authors.lastname: Song
authors.forename: Luyan
authors.initials: L
authors.lastname: Mu
authors.forename: Xuezhe
authors.initials: X
authors.lastname: Han
authors.forename: Qingla
authors.initials: Q
authors.lastname: Li
authors.forename: Baijing
authors.initials: B
authors.lastname: Dong
authors.forename: Hulun
authors.initials: H
authors.lastname: Li
authors.forename: Xiaoqian
authors.initials: X
authors.lastname: Liu
mesh_terms: D000818:Animals; D017209:Apoptosis; D015153:Blotting, Western; D001932:Brain Neoplasms / Q000098:blood supply* / Q000235:genetics / Q000378:metabolism; D002453:Cell Cycle; D049109:Cell Proliferation; D005910:Glioma / Q000098:blood supply* / Q000235:genetics / Q000378:metabolism; D006801:Humans; D007124:Immunoenzyme Techniques; D008156:Luciferases / Q000378:metabolism; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D035683:MicroRNAs / Q000235:genetics*; D009389:Neovascularization, Pathologic / Q000235:genetics / Q000517:prevention & control*; D012333:RNA, Messenger / Q000235:genetics; D034741:RNA, Small Interfering / Q000235:genetics; D060888:Real-Time Polymerase Chain Reaction; D020133:Reverse Transcriptase Polymerase Chain Reaction; D050777:Stathmin / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D014407:Tumor Cells, Cultured
chemical_list: C541874:MIRN92 microRNA, human; D035683:MicroRNAs; D012333:RNA, Messenger; D034741:RNA, Small Interfering; C493995:STMN1 protein, human; D050777:Stathmin; D008156:Luciferases
references.citation: J Clin Oncol. 2009 Dec 1;27(34):5848-56
references.pmid: 19884536
references.citation: Cancer Res. 2011 May 1;71(9):3410-21
references.pmid: 21531766
references.citation: J Neurosci. 2008 Oct 8;28(41):10415-21
references.pmid: 18842901
references.citation: Genes Dev. 2006 Oct 15;20(20):2793-805
references.pmid: 17015424
references.citation: Cancer Biol Ther. 2012 Mar;13(5):341-8
references.pmid: 22258034
references.citation: Gastroenterology. 2008 Jul;135(1):257-69
references.pmid: 18555017
references.citation: Cancer Res. 2008 Jul 1;68(13):5267-72
references.pmid: 18593927
references.citation: J Biomech. 1995 Dec;28(12):1471-84
references.pmid: 8666587
references.citation: Cell Stem Cell. 2010 Apr 2;6(4):323-35
references.pmid: 20362537
references.citation: Dev Cell. 2011 Jan 18;20(1):19-32
references.pmid: 21238922
references.citation: EMBO J. 2011 Aug 19;30(20):4309-22
references.pmid: 21857646
references.citation: Brain Pathol. 2009 Jul;19(3):375-83
references.pmid: 18624795
references.citation: Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Jun;30(3):268-74
references.pmid: 18686603
references.citation: J Pathol. 2006 Aug;209(4):549-58
references.pmid: 16739096
references.citation: Int J Cancer. 2000 Dec 1;88(5):685-91
references.pmid: 11072234
references.citation: Mol Med. 2007 Nov-Dec;13(11-12):567-75
references.pmid: 17873971
references.citation: Prostate. 2007 Jul 1;67(10):1038-52
references.pmid: 17455228
references.citation: J Natl Cancer Inst. 2007 Apr 18;99(8):639-52
references.pmid: 17440165
references.citation: J Neurosci. 2011 Jan 19;31(3):809-18
references.pmid: 21248104
references.citation: Cancer Biol Ther. 2008 Jul;7(7):1146-56
references.pmid: 18535405
references.citation: Stem Cells. 2006 Apr;24(4):857-64
references.pmid: 16357340
references.citation: Curr Opin Cell Biol. 2002 Feb;14(1):18-24
references.pmid: 11792540
references.citation: Cell Mol Life Sci. 2009 Oct;66(20):3263-76
references.pmid: 19585080
references.citation: APMIS. 2004 Jul-Aug;112(7-8):508-25
references.pmid: 15563313
references.citation: Oncogene. 2010 Oct 21;29(42):5724-8
references.pmid: 20676129
references.citation: Oncol Rep. 2012 Mar;27(3):714-8
references.pmid: 22038457
references.citation: Expert Rev Anticancer Ther. 2008 Sep;8(9):1461-70
references.pmid: 18759697
references.citation: J Biol Chem. 2008 Jan 4;283(1):453-460
references.pmid: 17984092
references.citation: Nucleic Acids Res. 2011 Aug;39(15):6440-55
references.pmid: 21572107
references.citation: Mol Cancer. 2008 Apr 28;7:35
references.pmid: 18442408
references.citation: Med Oncol. 2012 Mar;29(1):324-31
references.pmid: 21161444
references.citation: Am J Pathol. 1999 Sep;155(3):739-52
references.pmid: 10487832
references.citation: J Exp Clin Cancer Res. 2009 Jun 16;28:82
references.pmid: 19531230
references.citation: RNA. 2003 Oct;9(10):1274-81
references.pmid: 13130141
references.citation: Int J Cancer. 2009 Dec 1;125(11):2737-43
references.pmid: 19521961
references.citation: APMIS. 2008 Jan;116(1):27-32
references.pmid: 18254777
references.citation: Nat Cell Biol. 2010 Mar;12(3):247-56
references.pmid: 20173740
references.citation: Clin Cancer Res. 2007 May 15;13(10):2849-54
references.pmid: 17504982
references.citation: Mol Cancer. 2010 Jan 26;9:16
references.pmid: 20102618
references.citation: Exp Mol Med. 2011 May 31;43(5):298-304
references.pmid: 21464588
references.citation: Br J Cancer. 2006 Mar 13;94(5):717-23
references.pmid: 16495930
references.citation: Cell Cycle. 2010 Aug 1;9(15):2913-4
references.pmid: 20676037
references.citation: J Cell Biochem. 2004 Oct 1;93(2):242-50
references.pmid: 15368352
references.citation: Genome Med. 2011 Nov 28;3(11):77
references.pmid: 22122801
references.citation: Cancer Res. 2010 Jan 1;70(1):367-77
references.pmid: 20028871
references.citation: Oncogene. 2007 Feb 15;26(7):1003-12
references.pmid: 16909102